TIDMALK
RNS Number : 4175Y
Alkemy Capital Investments PLC
02 January 2024
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT
CONSTITUTE OR FORM ANY PART OF AN OFFER TO SELL OR ISSUE, OR A
SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE
ANY SECURITIES IN THE UNITED STATES, AUSTRALIA, THE REPUBLIC OF
SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH OFFER
OR SOLICITATION WOULD BE UNLAWFUL OR TO ANY PERSON TO WHOM IT IS
UNLAWFUL TO MAKE SUCH OFFER OR SOLICITATION. NO PUBLIC OFFERING OF
THE FUNDRAISE SHARES IS BEING MADE IN ANY SUCH JURISDICTION. ANY
FAILURE TO COMPLY WITH THESE RESTRICTIONS MAY CONSTITUTE A
VIOLATION OF THE SECURITIES LAWS OF SUCH JURISDICTIONS.
THIS ANNOUNCEMENT IS NOT FOR PUBLIC RELEASE, PUBLICATION OR
DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR
INTO THE UNITED STATES, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA,
JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION
OR DISTRIBUTION WOULD BE UNLAWFUL.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN
ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 ("MAR") AS IN
FORCE IN THE UNITED KINGDOM PURSUANT TO THE EUROPEAN UNION
(WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT,
THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC
DOMAIN.
2 January 2024
Alkemy Capital Investments Plc
Correction - Oversubscribed Placing to raise GBP650,000
Alkemy Capital Investments plc ("Alkemy") (LSE: ALK) notes the
following amendment to the "Oversubscribed Placing to raise
GBP650,000" announcement released on 18 December 2023. The new
ordinary shares are expected be admitted to trading on the Main
Market of the London Stock Exchange ("Admission") on or around 4
January 2024 and not 22 December 2023 as was originally stated. All
other details remain unchanged and the full amended text is shown
below:
Oversubscribed Placing to raise GBP650,000
Alkemy Capital Investments plc ("Alkemy") (LSE: ALK) is pleased
to announce that it has raised GBP650,000 in an oversubscribed
placing of 650,000 new ordinary shares at a placing price of GBP1
per share, being the total amount available under the Company's
existing share authorities.
This includes a subscription of GBP50,000 of shares at the
placing price from director Sam Quinn.
The net proceeds will be used to further the development of
TVL's lithium hydroxide processing facility in Teesside, UK and for
general working capital purposes ahead of the company seeking to
secure mezzanine financing for that facility, without diluting
Alkemy's shareholders.
Following the placing, the directors will have the following
beneficial shareholdings in the Company:
Number of Shares % of enlarged
capital
Paul Atherley 3,078,000 37.59%
----------------- --------------
Sam Quinn 446,428(1) 5.06%
----------------- --------------
Helen Pein 25,000 0.28%
----------------- --------------
Vikki Jeckell 0 0%
----------------- --------------
(1) Including shares held by Silvertree Partners in which Mr
Quinn has an interest
The placing is conditional upon and an application will be made
for 650,000 Ordinary Shares to be admitted to the official list
(Standard Segment) of the FCA and to trading on the Main Market of
the London Stock Exchange ("Admission") and Admission is expected
to occur at 8.00 a.m. on or around 4 January 2024.
In accordance with the FCA's Disclosure Guidance and
Transparency Rules, the Company confirms that following Admission,
the Company's enlarged issued ordinary share capital will comprise
8,814,851 Ordinary Shares each with a right to vote and with no
shares held in treasury. Therefore, following Admission, the above
figure may be used by shareholders in the Company as the
denominator for the calculations to determine if they are required
to notify their interest in, or a change to their interest in the
Company, under the FCA's Disclosure Guidance and Transparency
Rules.
In addition, 52,000 broker warrants are being issued in
conjunction with the placing, exerciseable at GBP1 per share for a
period of 2 years from Admission.
Alkemy Director Sam Quinn commented:
"We are grateful to all the existing and new shareholders who
have contributed to this fundraise, which will enable the further
development of TVL's lithium hydroxide processing facility in
Teesside, UK. Funds will be used to continue to advance FEED and
for G&A ahead of securing a non-dilutive mezzanine facility for
TVL which is targeted for early 2024. We appreciate the ongoing
support from all stakeholders and look forward to a successful 2024
as we move to establish the UK's first major independent and
sustainable lithium hydroxide producer at the Wilton International
Chemicals Park in Teesside, UK".
Further information
For further information, please visit the Company's website:
www.alkemycapital.co.uk or www.teesvalleylithium.co.uk
-Ends-
Alkemy Capital Investments Plc Tel: 0207 317 0636
info@alkemycapital.co.uk
SI Capital Limited Tel: 0148 341 3500
VSA Capital Limited Tel: 0203 005 5000
ABOUT ALKEMY CAPITAL
Alkemy is seeking to establish independent and sustainable
lithium hydroxide production by developing lithium sulphate and
lithium hydroxide facilities in the UK and Australia.
Alkemy, through its wholly owned UK subsidiary Tees Valley
Lithium, has secured a 9.6 ha brownfields site with full planning
permission at the Wilton International Chemicals Park in Teesside,
a major UK Freeport, to build the UK's first and one of Europe's
largest lithium hydroxide processing facility.
Tees Valley Lithium has completed a Class 4 Feasibility Study
for its proposed lithium hydroxide refinery which will process
feedstock imported from various sources to produce 96,000 tonnes of
premium, low-carbon lithium hydroxide or an equivalent amount of
lithium carbonate annually, representing around 15% of Europe's
projected demand.
Alkemy, through its wholly owned Australian subsidiary Port
Hedland Lithium, has secured a 43.7 ha site at the Boodarie
strategic industry area, near Port Hedland, Western Australia to
build a world-class sustainable lithium sulphate refinery that will
provide reliable feedstock for Tees Valley Lithium's refinery.
Port Hedland Lithium has completed a Class 4 Feasibility Study
for its proposed lithium sulphate refinery, each train of which
will process spodumene concentrate to produce 40,000 tonnes of
lithium sulphate annually.
Forward Looking Statements
This news release contains forward--looking information. The
statements are based on reasonable assumptions and expectations of
management and Alkemy provides no assurance that actual events will
meet management's expectations. In certain cases, forward--looking
information may be identified by such terms as "anticipates",
"believes", "could", "estimates", "expects", "may", "shall",
"will", or "would". Although Alkemy believes the expectations
expressed in such forward--looking statements are based on
reasonable assumptions, such statements are not guarantees of
future performance and actual results or developments may differ
materially from those projected. In addition, factors that could
cause actual events to differ materially from the forward-looking
information stated herein include changes in market conditions,
changes in metal prices, general economic and political conditions,
environmental risks, and community and non-governmental actions.
Such factors will also affect whether Alkemy will ultimately
receive the benefits anticipated pursuant to relevant agreements.
This list is not exhaustive of the factors that may affect any of
the forward--looking statements. These and other factors should be
considered carefully and readers should not place undue reliance on
forward-looking information.
The Notification of Dealing Form provided in accordance with the
requirements of the Market Abuse Regulation in relation to the
transaction listed above is set out below.
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Sam Quinn
--------------------------------------- -------------------------------------
Reason for the notification
2
------------------------------------------------------------------------------
a) Position/status Non-Executive Director
--------------------------------------- -------------------------------------
b) Initial notification Initial Notification
/Amendment
--------------------------------------- -------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
------------------------------------------------------------------------------
a) Name Alkemy Capital Investments PLC
--------------------------------------- -------------------------------------
b) LEI 213800NW5GVIRMXSRL48
--------------------------------------- -------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
------------------------------------------------------------------------------
a) Description of the Ordinary shares
financial instrument,
type of instrument
Identification code GB00BMD6C023
b) Nature of the transaction Subscription of shares
--------------------------------------- -------------------------------------
c) Price(s) and volume(s)
---------------- ----------------
Price(s) Volume(s)
---------------- ----------------
GBP1.00 50,000
------------------------------------------------------------- ----------------
d) Aggregated information
- Aggregated volume 50,000
- Price GBP1
e) Date of the transaction 18/12/2023
--------------------------------------- -------------------------------------
f) Place of the transaction Outside a trading venue
--------------------------------------- -------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEBUGDBLUGDGSD
(END) Dow Jones Newswires
January 02, 2024 12:00 ET (17:00 GMT)
Alkemy Capital Investments (LSE:ALK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkemy Capital Investments (LSE:ALK)
Historical Stock Chart
From Apr 2023 to Apr 2024
